Yong Zhang, MD, PhD
Titles
Chief Physician of Nuclear Medicine
Doctoral Student Supervisor
Chief of Graduate Management Section, the Third Affiliated Hospital of Sun Yat-sen University.
Committee member of Radiological Medicine and Protection of Chinese Medical Association
Vice chairman of Radiological Medicine and Protection of Guangdong Medical Association
Committee member of Nuclear Medicine of Guangdong Medical Association
Standing committee member of Nuclear Medicine of Guangdong Medical Doctor Association
Research Interests
Antigene radiotherapy for prostate cancer
Supported by Chinese National Natural Science Foundation and Guangdong Provincial Natural Science Foundation.
Radioimmunotherapy for prostate cancer
Supported by Ph.D. Programs Foundation of Ministry of Education of China and Guangdong Province Science and Technology Programs.
Annimal model construction for prostate cancer
Supported by Guangdong Province Science and Technology Programs.
Nuclear medicine imaging clinical research
Supported by Guangzhou Science and Technology Programs.
Education and Experience
Education Training
Master’s degree, School of Medicine, Sun Yat-sen University (1993-1996)
Doctoral degree, School of Medicine, Sun Yat-sen University (2001-2004)
Continue education (short term education)
Intensive clinical research ethics course by Johns Hopkins University School of Medicine (2014)
International GP trainers programme by Birmingham University School of Health and Population Sciences (2015)
Experience
Physician, Lu An people’s hospital in Anhui province (1990-1993)
Attending doctor, the Third Affiliated Hospital of Sun Yat-sen University (1997-2003)
Vice Chief Physician, the Third Affiliated Hospital of Sun Yat-sen University (2003-2009)
Chief Physician, the Third Affiliated Hospital of Sun Yat-sen University (2009-present)
Certification
Nuclear Medicine Certified License in Guangdong Province, China (2001)
Honors and Awards
The third prize of Guangdong Provincial Science and Technology Award (2014)
Reviewer of National Major Science and Technology Special Projects (2016)
Reviewer of National Natural Science Foundation (2010-2016)
Reviewer of Science and Technology Award of Guangdong Province and Macao Special Administrative Region
Publications
1.Li XP, Jiao JU, Lu LI, Zou Q, Zhu S, Zhang Y. Overexpression of ribosomal L1 domain containing 1 is associated with an aggressive phenotype and a poor prognosis in patients with prostate cancer. Oncol Lett. 2016 Apr;11(4):2839-2844. (corresponding author)
2.Qiong Zou , Ju Jiao, Min-Hong Zou, Jie-Hua Xu, Yun-Feng Pan, Jian-Ning Chen & Mu-Hua Cheng , Feng Zhang, Yong Zhang. Semi-quantitative evaluation of salivary gland function in Sjögren's syndrome using salivary gland scintigraphy. Clin Rheumatol (2012) 31:1699–1705（corresponding author）
3.Jia-Jun Liu ,Wen-Da Liu, Hong-Zhi Yang, Yong Zhang, Zhi-Gang Fang, Pei-Qing Liu, Dong-Jun Lin, Ruo-Zhi Xiao, Yuan Hu, Chun-Zhi Wang, Xu-Dong Li, Yi He, Ren-Wei Huang. Inactivation of PI3k/Akt signaling pathway and activation of caspase-3 are involved in tanshinone I-induced poptosis in myeloid leukemia cells in vitro. Ann Hematol, 2010, 89:1089–1097（Co first author）
4.Wang CZ, Zhang Y, Li XD, Hu Y, Fang ZG, Lin DJ, Xiao RZ, Huang RW, Huang HQ, Liu PQ, Liu JJ. PPARc Agonist Suppresses TLR4 Expression and TNF-a Production in LPS Stimulated Monocyte Leukemia Cells. Cell Biochem Biophys. 2011, 60(3):167-72. （Co first author）
5.Liu JJ, Dai XJ, Xu Y, Liu PQ, Zhang Y, Liu XD, Fang ZG, Lin DJ, Xiao RZ, Huang RW, Huang HQ. Inhibition of Lymphoma Cell Proliferation by Peroxisomal Proliferator-Activated Receptor-c Ligands via Wnt Signaling Pathway. Cell Biochem Biophys. 2012, 62(1):19-27.（corresponding author）
6.Zhang Y, Ma Y, Lu HP, Gao JH, Liang CS, Liu CZ, Zou JT, Wang HQ. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helin forming oligonucleotide directed against androgen receptor. Chin Med J (Engl). 2008, 121(22):2284-9. （corresponding author）
7.Liu XD, Fan RF, Zhang Y, Yang HZ, Fang ZG, Guan WB, Lin DJ, Xiao RZ, Huang RW, Huang HQ, Liu PQ, Liu JJ. Down-Regulation of Telomerase Activity and Activation of Caspase-3 Are Responsible for Tanshinone I-Induced Apoptosis in Monocyte Leukemia Cells in Vitro. Int J Mol Sci. 2010, 11(6):2267-80.（Co first author）
8.Liu JJ, Zhang Y, Guang WB, Yang HZ, Lin DJ, Xiao RZ. Ponicidin Inhibits Monocytic Leukemia Cell Growth by Induction of Apoptosis. Int J Mol Sci. 2008 , 9(11):2265-77. （Co first author）
9.Jia-Jun Liu, Yan-Xu, Yong Zhang, Ruo-Zhi Xiao, Dong-Jun Lin. Peroxisome Proliferator-Activated Receptor γ (PPAR-γ) Agonist Rosiglitazone (RGZ) Inhibits HL-60 Cell Growth by Induction of Apoptosis. LABMEDICINE. 2009, 40(5): 297-302（corresponding author）
10.Zou M, Jiao J, Zou Q, Xu Y, Cheng M, Xu J, Zhang Y. Multiple metastases in a novel LNCaP model of human prostate cancer. Oncol Rep. 2013, 30(2):615-22.（corresponding author）
Contact
The Third Affiliated Hospital of Sun Yat-sen University
600 Tianhe Road, Tianhe District, Guangzhou.
Guangdong Province, China, 510630.
Appointment Phone: +86-20-85253137
